NCGR, Aiming to Diversify Platforms, Acquires Five SOLiD 4 Instruments
September 07, 2010
NCGR, Aiming to Diversify Platforms, Acquires Five SOLiD 4 Instruments
NCGR has been exclusively using the Illumina Genome Analyzer as its next-generation sequencing platform. Adding the SOLiD machines is part of a strategy to diversify the center's offerings.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Clinical Genome Sequencing Requires Better Standards for Accuracy, Completeness, NHGRI Team Says
August 24, 2011 / Clinical Sequencing News - Illumina, Helicos Platforms Offer Distinct Advantages for Ancient DNA Sequencing, Danish Group Says
August 23, 2011 / In Sequence - New Products
July 19, 2011 / In Sequence - Q&A: Life Tech CMO Paul Billings on Moving Next-Gen Sequencing from the Bench to the Bedside
July 13, 2011 / Clinical Sequencing News - AltheaDx Explores Desktop NGS Platforms for Cancer Gene Panels
July 6, 2011 / Clinical Sequencing News